Carnitine in the treatment of geriatric depression

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/205 (2006.01) A61P 25/24 (2006.01)

Patent

CA 2469925

This invention relates to use of a carnitine selected from L-carnitine or alkanoyl L-carnitine, preferably acetyl L-carnitine, or of a pharmaceutically acceptable salt thereof for the preparation of a medicament useful for treating depression in a subject, particularly geriatric subjects. The advantage of the invention stands in the efficacy of the carnitine and the lack of important side effects typical of well-known antidepressants.

Cette invention porte sur l'utilisation d'une carnitine sélectionnée parmi L-carnitine ou alkanoyle L-carnitine, de préférence acétyle L-carnitine ou d'un sel acceptable d'un point e vue pharmaceutique de celle-ci dans la préparation d'un médicament utile pour traiter la dépression chez un sujet, notamment les vieillards. L'avantage de cette invention repose sur l'efficacité de la carnitine et l'absence d'effets secondaires importants typiques des antidépresseurs notoirement connus.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Carnitine in the treatment of geriatric depression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Carnitine in the treatment of geriatric depression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carnitine in the treatment of geriatric depression will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1458026

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.